Drug Trial Radar · NCT07185321
A Phase 1 Study of Mosliciguat in Healthy, Adult Males
Last checked: Nov 19, 2026Latest source record: Jun 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
8
Actual
Start
Jun 10, 2025
Primary completion
Jun 30, 2025
Study completion Jul 13, 2025
Sponsor
- Lead sponsor
- Pulmovant, Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 22, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a single-center, Phase 1, open-label, 3-period, fixed-sequence study to investigate the bioavailability, absorption, metabolism, excretion and the safety of mosliciguat administered to healthy male adults.
Conditions
- Healthy Volunteer
Interventions
MosliciguatDrug
Dose level for inhalation
14C mosliciguatDrug
Dose level
Dry Powder InhalerDevice
Dry powder inhaler for mosliciguat
Primary outcomes
What the sponsor says the trial is designed to measure.
- Determine the absolute bioavailability (ABA) of mosliciguat following administration of a single inhaled dose of mosliciguat followed by an IV microtracer dose of [14C]-mosliciguat in healthy adult malesTime frame: Baseline, Day 7
- Area under the concentration-time curve (AUC) for mosliciguatTime frame: Baseline, Day 7
- Assess the mass balance (i.e., cumulative excretion in urine and feces compared to the administered amount of radioactive isotope) of [14C] following a single oral dose of mosliciguat solutionTime frame: Baseline, Day 28
- Maximum observed concentration (Cmax)Time frame: Baseline, Day 7
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Pharmaron
Baltimore, Maryland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.